Pirenoxine CAS 1043-21-6 is a medication used in the possible treatment and prevention of cataracts. We use superior quality ingredient and precise formulation to ensure Pirenoxine CAS NO 1043-21-6 is high specification. Strict quality assurance measures are undertaken by some of the most quality controllers to ensure the customers the most efficient and superior quality products at all times. Our inventory keep gram grade to kilogram grade so that can meet customers requirements in time.

Thera. Category: anti-cataract agent

Cas No.: 1043-21-6

Synonym: 1-Hydroxy-5-oxo-5H-pyrido[3,2-]phenoxazine-3-carboxylicacid;Bernetine;catalin;PIRENOXINE;1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylic acid;1-Hydroxy-3-carboxy-5H-pyrido[3,2-a]phenoxazin-5-one;1-Hydroxy-5H-pyrido[3,2-a]phenoxazin-5-one-3-carboxylic acid;5H-Pyrido[3,2-a]phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo-

Molecular Formula: C16H8N2O5

Molecular Weight: 308.25

Assay: ≥97.%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage: Catalin (Pirenoxine) CAS 1043-21-6 is an anti-cataract agent used to inhibit the development of cataracts in patients considered at risk. Its mechanism of action is interacting with calcium and selenite ions, which are known to play a central role in the formation of lens cataracts. This in turn can help stop crystals in the eye that are water soluble from insolubilization, which allows for the eye lens and vision to remain clear. Another medical study showed that it might be effective in helping preventing an oxidative attack on the eye lens, which could further explain its potential as a treatment for cataract prevention